Variable Interval Versus Set Interval Aflibercept for DME

Summary

The purpose of this study is to compare the safety and efficacy of intravitreal Eylea injections at a set interval, versus a variable dosing schedule (likely longer than one month), based on a specific individual's disease progression. There will be approximately 50 men and women at least 18 years of age, diagnosed with type 1 or type 2 diabetes, taking part in this study at 5 locations in the United States.

Timeline

Start

2015-04-15

Primary completion

2018-11-15

Completion

2018-11-15

Drugs

Indications